PRESENTERS: DR. STACI L. GRUBER AND DR. KELLY SAGAR
MODERATOR: DEBRA P. DOW, ESQ., ESSEX COUNTY REGIONAL COORDINATOR, MHLD
REGISTER HERE: https://us06web.zoom.us/meeting/register/alUIkg2ZQk-EFRL5Wg_-HQ
Many of us have experienced cases where clients use marijuana, and we have anecdotally noted that there seems to be an effect on, and correlation with, our client’s mental health from that usage. Come hear from the experts on this important topic that we encounter. The doctors understand they are likely to receive specific questions on the interplay with antipsychotic medications.
- Understand important distinctions between medical and recreational cannabis use
- Identify cannabis-related and individual-specific factors that influence the relationship between cannabis use and mental health
- Summarize findings from clinical trials assessing the impact of CBD and high-CBD products in individuals with anxiety
ABOUT THE EXPERTS:
Dr. Gruber is the Director of Cognitive and Clinical Neuroimaging Core and Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s research focuses on the application of neurocognitive models and multimodal brain imaging to better characterize neurobiological risk factors for substance use and psychiatric conditions, and to assess the impact of cannabis and cannabinoid exposure on outcomes related to brain health, cognition, and clinical state.
Dr. Sagar is a member of the Gruber Lab and is an Instructor in Psychiatry at Harvard Medical School. Dr. Sagar works in the Cognitive and Clinical Neuroimaging Core (CCNC) as well as the MIND programs at McLean Hospital. She has received multiple awards and has co-authored several papers on recreational and medical cannabis use as well as bipolar disorder.